From GlobeNewswire: 2024-06-24 07:00:00

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) has decided to terminate its employees and wind down operations, including evaluating strategic alternatives for its development programs. The Company’s securities may be delisted from the Nasdaq Stock Market if compliance is not regained. Craig R. Jalbert has been appointed as the CEO and President, and will oversee the company’s wind-down phase. The decision was made by the board of directors at a special meeting. eFFECTOR cautions that forward-looking statements in the press release may differ from actual results due to uncertainties and risks inherent in the business.



Read more at GlobeNewswire: eFFECTOR Therapeutics Announces it will Wind Down